GATIFLOXACIN — all Canadian products
8 DINs
2 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is GATIFLOXACIN, with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02533235 | JAMP GATIFLOXACIN | JAMP PHARMA CORPORATION | Solution | Ophthalmic | GATIFLOXACIN 0.3 % | Marketed | |
| 02257270 | ZYMAR | ABBVIE CORPORATION | Solution | Ophthalmic | GATIFLOXACIN 0.3 % | Marketed | |
| 02271052 | NOVO-GATIFLOXACIN | NOVOPHARM LIMITED | Tablet | Oral | GATIFLOXACIN 400 MG | Cancelled Pre Market | |
| 02408481 | SANDOZ GATIFLOXACIN | SANDOZ CANADA INCORPORATED | Solution | Ophthalmic | GATIFLOXACIN 3 MG | Cancelled Pre Market | |
| 02243181 | TEQUIN | BRISTOL-MYERS SQUIBB CANADA | Tablet | Oral | GATIFLOXACIN 200 MG | Cancelled Post Market | |
| 02243182 | TEQUIN | BRISTOL-MYERS SQUIBB CANADA | Tablet | Oral | GATIFLOXACIN 400 MG | Cancelled Post Market | |
| 02243183 | TEQUIN IV | BRISTOL-MYERS SQUIBB CANADA | Solution | Intravenous | GATIFLOXACIN 2 MG | Cancelled Post Market | |
| 02243184 | TEQUIN IV | BRISTOL-MYERS SQUIBB CANADA | Liquid | Intravenous | GATIFLOXACIN 10 MG | Cancelled Post Market |
Browse other molecules: